NCT06462521

Brief Summary

The study will compare the use of cold snare piecemeal resection (CSPR) vs cold endoscopic mucosal resection (Cold EMR). The study will include two cohorts: one cohort for conventional adenomas 10-19mm in size and one cohort for serrated lesions 10mm or larger.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
570

participants targeted

Target at P75+ for not_applicable

Timeline
24mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Sep 2024Jul 2028

First Submitted

Initial submission to the registry

June 12, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 17, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 6, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

December 30, 2025

Status Verified

September 1, 2025

Enrollment Period

2.8 years

First QC Date

June 12, 2024

Last Update Submit

December 22, 2025

Conditions

Keywords

Polyp ResectionCold SnareCold Endoscopic Mucosal Resection (Cold EMR)Cold Snare Piecemeal Resection (CSPR)Colonoscopy

Outcome Measures

Primary Outcomes (2)

  • Efficacy of Resection (Central Post-Resection Biopsies)

    Efficacy of resection will be assessed by biopsies in four or six quadrants of the perimeter of the defect post-resection and two biopsies from the center of the defect post-resection. Comparison of the biopsy pathology results for polyps removed by Cold EMR vs CSPR.

    1 day

  • Efficacy of Resection (Peripheral Post-Resection Biopsies)

    Efficacy of resection will be assessed by biopsies in four or six quadrants of the perimeter of the defect post-resection and two biopsies from the center of the defect post-resection. Comparison of the biopsy pathology results for polyps removed by Cold EMR vs CSPR.

    1 day

Secondary Outcomes (5)

  • Polyp Resection Time

    1 day

  • Resection Preparation Time

    1 day

  • Total Procedure Time

    1 day

  • Adverse Events

    30 Days

  • Rate of Recurrence at First Surveillance Colonoscopy for Polyps ≥ 20mm

    At first surveillance colonoscopy, typically 6 months to 12 months

Study Arms (2)

Cold Snare Piecemeal Resection (CSPR)

EXPERIMENTAL

Conventional adenomas sized 10-19mm or serrated lesions 10mm or larger found during colonoscopy will be removed using CSPR technique.

Procedure: Cold Snare Piecemeal Resection (CSPR)

Cold Snare Endoscopic Mucosal Resection (Cold EMR)

EXPERIMENTAL

Conventional adenomas sized 10-19mm or serrated lesions 10mm or larger found during colonoscopy will be removed using Cold EMR technique.

Procedure: Cold Snare Endoscopic Mucosal Resection (Cold EMR)

Interventions

Qualifying polyps randomized to Cold Snare Piecemeal Resection (CSPR) will be removed using cold snare techniques (no electrocautery, no submucosal injection.)

Cold Snare Piecemeal Resection (CSPR)

Qualifying polyps randomized to Cold Snare Endoscopic Mucosal Resection (Cold EMR) will be removed using cold snare techniques (no electrocautery, with submucosal injection.)

Cold Snare Endoscopic Mucosal Resection (Cold EMR)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years of age
  • Presenting for a screening, surveillance, diagnostic, or therapeutic colonoscopy
  • Found to have:
  • a sessile serrated lesion or hyperplastic polyp ≥ 10 mm during procedure (Serrated Cohort) or
  • a 10-19 mm conventional adenoma during procedure (Adenoma Cohort)
  • Ability to provide informed consent

You may not qualify if:

  • Pedunculated or semi-pedunculated polyps (as defined by Paris Classification type Ip or Isp)
  • Polyps confirmed to be anything other than:
  • sessile serrated lesion or hyperplastic polyp on histologic diagnosis (Serrated Cohort) or
  • conventional adenoma on histologic diagnosis (Adenoma Cohort)
  • Patients with Ulcerative Colitis or Crohn's disease
  • Polyps with features suggestive of submucosal invasion
  • Polyps that are not able to be removed endoscopically due to location (e.g. extending into appendiceal orifice or diverticulum)
  • Patients with a known or suspected diagnosis of any of the following polyposis syndromes with known genetic mutations:
  • Familial Adenomatous Polyposis Syndrome
  • MUTYH associated Polyposis Syndrome
  • Juvenile Polyposis Syndrome
  • Cowden's Syndrome
  • Peutz-Jeghers Syndrome
  • Subjects whose colonoscopy procedure is not able to be completed due to bowel prep precluding polyp identification.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Indianapolis, Indiana, 46202, United States

Location

Related Publications (7)

  • Kaltenbach T, Anderson JC, Burke CA, Dominitz JA, Gupta S, Lieberman D, Robertson DJ, Shaukat A, Syngal S, Rex DK. Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 Mar;158(4):1095-1129. doi: 10.1053/j.gastro.2019.12.018. Epub 2020 Feb 11. No abstract available.

    PMID: 32122632BACKGROUND
  • von Renteln D, Djinbachian R, Benard F, Barkun AN, Bouin M, Bouchard S, Deslandres E, Panzini B, Sidani S, Leduc R, Jobse BC, Pohl H. Incomplete resection of colorectal polyps of 4-20 mm in size when using a cold snare, and its associated factors. Endoscopy. 2023 Oct;55(10):929-937. doi: 10.1055/a-1978-3277. Epub 2022 Nov 14.

    PMID: 36377124BACKGROUND
  • McWhinney CD, Vemulapalli KC, El Rahyel A, Abdullah N, Rex DK. Adverse events and residual lesion rate after cold endoscopic mucosal resection of serrated lesions >/=10 mm. Gastrointest Endosc. 2021 Mar;93(3):654-659. doi: 10.1016/j.gie.2020.08.032. Epub 2020 Sep 3.

  • Rex DK, Anderson JC, Pohl H, Lahr RE, Judd S, Antaki F, Lilley K, Castelluccio PF, Vemulapalli KC. Cold versus hot snare resection with or without submucosal injection of 6- to 15-mm colorectal polyps: a randomized controlled trial. Gastrointest Endosc. 2022 Aug;96(2):330-338. doi: 10.1016/j.gie.2022.03.006. Epub 2022 Mar 12.

  • Kimoto Y, Sakai E, Inamoto R, Kurebayashi M, Takayanagi S, Hirata T, Suzuki Y, Ishii R, Konishi T, Kanda K, Negishi R, Takita M, Ono K, Minato Y, Muramoto T, Ohata K. Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e132-e138. doi: 10.1016/j.cgh.2020.10.053. Epub 2020 Nov 2.

  • Mangira D, Raftopoulos S, Vogrin S, Hartley I, Mack A, Gazelakis K, Nalankilli K, Trinh A, Metz AJ, Appleyard M, Grimpen F, Elliott T, Brown G, Moss A. Effectiveness and safety of cold snare polypectomy and cold endoscopic mucosal resection for nonpedunculated colorectal polyps of 10-19 mm: a multicenter observational cohort study. Endoscopy. 2023 Jul;55(7):627-635. doi: 10.1055/a-2029-9539. Epub 2023 Feb 7.

  • Gupta S, Lieberman D, Anderson JC, Burke CA, Dominitz JA, Kaltenbach T, Robertson DJ, Shaukat A, Syngal S, Rex DK. Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 Mar;158(4):1131-1153.e5. doi: 10.1053/j.gastro.2019.10.026. Epub 2020 Feb 7. No abstract available.

MeSH Terms

Conditions

Colonic NeoplasmsColonic Polyps

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesIntestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • John J Guardiola, MD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Medicine

Study Record Dates

First Submitted

June 12, 2024

First Posted

June 17, 2024

Study Start

September 6, 2024

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

December 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

De-identified data may be shared in the future upon request per PI discretion.

Locations